Pictet Asset Management (UK)’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $73.6M | Buy |
847,723
+108,741
| +15% | +$9.44M | 0.08% | 276 |
|
|
2021
Q1 | $60.9M | Buy |
738,982
+146,729
| +25% | +$12.1M | 0.07% | 292 |
|
|
2020
Q4 | $53.9M | Sell |
592,253
-725,747
| -55% | -$66M | 0.07% | 294 |
|
|
2020
Q3 | $52.7M | Buy |
1,318,000
+20,221
| +2% | +$808K | 0.08% | 267 |
|
|
2020
Q2 | $44.5M | Buy |
1,297,779
+731,467
| +129% | +$25.1M | 0.08% | 268 |
|
|
2020
Q1 | $12.6M | Sell |
566,312
-667,285
| -54% | -$14.8M | 0.03% | 433 |
|
|
2019
Q4 | $24.1M | Buy |
1,233,597
+112,479
| +10% | +$2.2M | 0.04% | 388 |
|
|
2019
Q3 | $17.4M | Buy |
1,121,118
+775,700
| +225% | +$12M | 0.04% | 410 |
|
|
2019
Q2 | $7.01M | Buy |
+345,418
| New | +$7.01M | 0.02% | 600 |
|